Denali Therapeutics Inc. Quarterly Revenues in USD from Q1 2018 to Q1 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary: Denali Therapeutics Inc. quarterly/annual Revenues history and growth rate from Q1 2018 to Q1 2024.
Denali Therapeutics Inc. Revenues for the quarter ending March 31, 2024 was $0.000, a 100% decline year-over-year.
Denali Therapeutics Inc. Revenues for the twelve months ending March 31, 2024 was $295M, a 191% increase year-over-year.
Denali Therapeutics Inc. annual Revenues for 2023 was $331M, a 205% increase from 2022.
Denali Therapeutics Inc. annual Revenues for 2022 was $108M, a 123% increase from 2021.
Denali Therapeutics Inc. annual Revenues for 2021 was $48.7M, a 85.5% decline from 2020.

Revenues, Trailing 12 Months (USD)

Revenues, Quarterly (USD)

Revenues, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024	$295M	$0	-$35.1M	-100%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-07
Q4 2023	$331M	$0	-$10.3M	-100%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-28
Q3 2023	$341M	$1.27M	-$2.29M	-64.4%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-07
Q2 2023	$343M	$294M	+$242M	+460%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-08
Q1 2023	$101M	$35.1M	-$7M	-16.6%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-07
Q4 2022	$108M	$10.3M	-$2.23M	-17.8%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-28
Q3 2022	$111M	$3.56M	-$1.73M	-32.7%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-07
Q2 2022	$112M	$52.5M	+$29.5M	+129%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-08
Q1 2022	$82.9M	$42.1M	+$34.2M	+432%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-08
Q4 2021	$48.7M	$12.5M	-$304M	-96.1%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-28
Q3 2021	$353M	$5.29M	-$4.11M	-43.7%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-03
Q2 2021	$357M	$22.9M	+$17.1M	+292%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-08
Q1 2021	$340M	$7.92M	+$4.32M	+120%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-05
Q4 2020	$336M	$317M	+$312M	+6681%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-27
Q3 2020	$23.5M	$9.39M	-$4.21M	-31%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-04
Q2 2020	$27.7M	$5.85M	+$1.65M	+39.3%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-04
Q1 2020	$26.1M	$3.6M	-$601K	-14.3%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-05
Q4 2019	$26.7M	$4.67M			Oct 1, 2019	Dec 31, 2019	10-K	2022-02-28
Q3 2019		$13.6M			Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-05
Q2 2019		$4.2M			Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-07
Q1 2019		$4.21M	+$3.56M	+556%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-07
Q1 2018		$641K			Jan 1, 2018	Mar 31, 2018	10-Q	2018-05-11

* An asterisk sign (*) next to the value indicates that the value is likely invalid.